Harrison Linda J, Brummel Sean S
Center for Biostatistics in AIDS Research, Department of Biostatistics, Harvard T.H. Chan School of Public Health.
Am Stat. 2025;79(3):383-392. doi: 10.1080/00031305.2025.2468399. Epub 2025 Apr 7.
Recently, the International Conference on Harmonisation finalized an estimand framework for randomized trials that was adopted by regulatory bodies worldwide. The framework introduced five strategies for handling post-randomization events; namely the treatment policy, composite variable, while on treatment, hypothetical and principal stratum estimands. We describe an illustrative example to elucidate the difference between these five strategies for handling intercurrent events and provide an estimation technique for each. Specifically, we consider the intercurrent event of treatment discontinuation and introduce potential outcome notation to describe five estimands and corresponding estimators: 1) an intention-to-treat estimator of the total effect of a treatment policy; 2) an intention-to-treat estimator of a composite of the outcome and remaining on treatment; 3) a per-protocol estimator of the outcome in individuals observed to remain on treatment; 4) a g-computation estimator of a hypothetical scenario that all individuals remain on treatment; and 5) a principal stratum estimator of the treatment effect in individuals who would remain on treatment under the experimental condition. Additional insight is provided by defining situations where certain estimands are equal, and by studying the while on treatment strategy under repeated outcome measures. We highlight relevant causal inference literature to enable adoption in practice.
最近,国际协调会议敲定了一项随机试验的估计量框架,该框架被全球监管机构采用。该框架引入了五种处理随机化后事件的策略;即治疗策略、复合变量、治疗期间、假设和主要分层估计量。我们描述了一个示例,以阐明这五种处理并发事件策略之间的差异,并为每种策略提供一种估计技术。具体而言,我们考虑治疗中断这一并发事件,并引入潜在结果符号来描述五种估计量和相应的估计器:1)治疗策略总效应的意向性分析估计器;2)结局与继续治疗复合指标的意向性分析估计器;3)观察到继续治疗的个体结局的符合方案估计器;4)假设所有个体都继续治疗的g计算估计器;5)在实验条件下会继续治疗的个体的治疗效果主要分层估计器。通过定义某些估计量相等的情况,以及研究重复结局测量下的治疗期间策略,我们提供了更多见解。我们重点介绍了相关的因果推断文献,以便在实践中采用。